EREG is usually overexpressed in various cancers, including glioma and lung cancer; however, whether the expression of EREG plays a critical role in distinct types of cancers with CSC properties that confer tumor metastasis and drug resistance remains unclear. This evidence concerns the gene EREG and central nervous system cancer.